Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, et al.
EBioMedicine (2023) Vol. 88, pp. 104435-104435
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Tracking the COVID-19 vaccines: The global landscape
Tushar Yadav, Swatantra Kumar, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
Guy Gorochov, Jacques Ropers, Odile Launay, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e248051-e248051
Open Access | Times Cited: 14
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
Jun Liu, Li Wang, Alexandra Kurtesi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
Peter Kirwan, Victoria Hall, Sarah Foulkes, et al.
The Lancet Regional Health - Europe (2023) Vol. 36, pp. 100809-100809
Open Access | Times Cited: 11
Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva
Stephan Winklmeier, Heike Rübsamen, Ceren Özdemir, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Immune Response to COVID-19 Vaccination in Frontline Healthcare Workers
Birutė Strukčinskienė, Zydre Valotkiene, Jonas Jurgaitis, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 199-199
Open Access | Times Cited: 3
Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults
Andrea Padoan, Chiara Cosma, Costanza Di Chiara, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 6-6
Open Access | Times Cited: 2
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge
Lindsay Hill-Batorski, Richard A. Bowen, Helle Bielefeldt‐Ohmann, et al.
Vaccine (2024) Vol. 42, Iss. 11, pp. 2770-2780
Closed Access | Times Cited: 2
Subclinical SARS-CoV-2 Infections and Endemic Human Coronavirus Immunity Shape SARS-CoV-2 Saliva Antibody Responses
Tonia L. Conner, Emilie Goguet, Hannah Haines-Hull, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5
Franziska Krenn, Christopher Dächert, Irina Badell, et al.
Medical Microbiology and Immunology (2023) Vol. 212, Iss. 5, pp. 323-337
Open Access | Times Cited: 7
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
Cristiana Perrotta, Claudio Fenizia, Carla Carnovale, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1481-1481
Open Access | Times Cited: 4
Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination
Matthaios Speletas, Ioanna Voulgaridi, Zacharoula Bogogiannidou, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 12-12
Open Access | Times Cited: 4
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
Maggie Jing Ouyang, Zhujun Ao, Titus Abiola Olukitibi, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 3
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
Daniela Dalla Gasperina, Giovanni Veronesi, Carlo Maria Castelletti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13728-13728
Open Access | Times Cited: 3
Oral immunization with rVSV bivalent vaccine elicits protective immune responses, including ADCC, against both SARS-CoV-2 and Influenza A viruses
Maggie Jing Ouyang, Zhujun Ao, Titus Abiola Olukitibi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults
Andrea Padoan, Chiara Cosma, Costanza Di Chiara, et al.
(2023)
Open Access | Times Cited: 2
Insufficient anti-spike RBD IgA responses after triple vaccination with intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2
Michinobu Yoshimura, Atsuhiko Sakamoto, Ryo Ozuru, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23595-e23595
Open Access | Times Cited: 2
Recent Patterns and Assessment of Long-term Complications followi ng SARS-CoV-2 Infection and Vaccination in the Context of Diabet es Prevalence among Blood Donors
Turki Mohammed M. Alqahtani, Mohammed Abdullah Alghamdi, Mirza Baig, et al.
Current Diabetes Reviews (2024) Vol. 20, Iss. 9
Closed Access
The presence of ACE2 and regulatory miRNAs (miR-200c-3p and miR-421-5p) in the saliva of periodontitis patients post-COVID-19 vaccination
Boy M. Bachtiar, Natalina Haerani, Yuniarti Soeroso, et al.
Frontiers in Dental Medicine (2024) Vol. 5
Open Access
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
Gregory Morgan, Chun Yiu Jordan Fung, Anne‐Claude Gingras, et al.
Clinical Biochemistry (2024), pp. 110859-110859
Open Access
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
Gabriel Diem, Stefanie Dichtl, Viktoria Zaderer, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top